Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-02-013050
Filing Date
2002-04-01
Accepted
2002-04-01 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2074492z10-k405.htm 10-K405 484386
3 EXHIBIT 10.24 a2074492zex-10_24.txt EX-10.24 20003
4 EXHIBIT 10.25 a2074492zex-10_25.txt EX-10.25 21594
5 EXHIBIT 10.26 a2074492zex-10_26.txt EX-10.26 30056
6 EXHIBIT 10.27 a2074492zex-10_27.txt EX-10.27 34930
7 EXHIBIT 10.28 a2074492zex-10_28.txt EX-10.28 10777
8 EXHIBIT 10.29 a2074492zex-10_29.txt EX-10.29 88778
9 EXHIBIT 10.30 a2074492zex-10_30.txt EX-10.30 21313
  Complete submission text file 0000912057-02-013050.txt   714179
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE ST BLDG 400 CAMBRIDGE MA 02139 6175885300
VARIAGENICS INC (Filer) CIK: 0001043082 (see all company filings)

EIN.: 043182077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-31035 | Film No.: 02597801
SIC: 8731 Services-Commercial Physical & Biological Research